Total Synthesis and Preliminary Biological Evaluation of cis-Solamin Isomers

Journal of Organic Chemistry

Volumn 69, Issue 10, 2004, Pages 3368-3374

  Cecil, Alex R L ^a   Hu, Yulai ^a   Vicent, María J ^b   Duncan, Ruth ^b   Brown, Richard C D ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDES; OXIDATION; STEREOCHEMISTRY; SYNTHESIS (CHEMICAL); TOXICITY;

CHEMOSELECTIVITY; OXIDATIVE CYCLIZATION; STEREOCENTERS;

ISOMERS;

4,5 DIDEHYDROSOLAMIN; ACETOGENIN; SOLAMIN; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHIRALITY; CYTOTOXICITY; HEMOLYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFRARED SPECTROSCOPY; INSECTICIDAL ACTIVITY; MASS SPECTROMETRY; PROTON NUCLEAR MAGNETIC RESONANCE; STEREOCHEMISTRY; SYNTHESIS;

ANIMALS; BENZETHONIUM; CELL LINE, TUMOR; CELL SURVIVAL; CYCLIZATION; EPOXY COMPOUNDS; INHIBITORY CONCENTRATION 50; ISOMERISM; MOLECULAR STRUCTURE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 2442682076     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo049909g     Document Type: Article

References (85)

1. (a) Rupprecht, J. K.; Hui, Y. H.; McLaughlin, J. L. J. Nat. Prod. 1990, 53, 237-278.
2. (b) Cavé, A.; Cortes, D.; Figadère, B.; Hocquemiller, R.; Laprévote, O.; Laurens, A.; Leboeuf, M. In Recent Advances in Phytochemistry; Downum, K. R., Ed.; Plenum Press: New York, 1993; Vol. 27, pp 167-202.
3. (c) Zafra-Polo, M. C.; Gonzalez, M. C.; Estornell, E.; Sahpaz, S.; Cortes, D. Phytochemistry 1996, 42, 253-271.
4. (d) Zeng, L.; Ye, Q.; Oberlies, N. H.; Shi, G.; Gu, Z. M.; He, K.; McLaughlin, J. L. Nat. Prod. Rep. 1998, 13, 275-306.
5. (e) Cavé, A.; Figadère, B.; Laurens, A.; Cortes, D. In Progress in the Chemistry of Organic Natural Products; Herz, W., Kirby, G. W., Moore, R. E., Steglish, W., Tamm, C., Eds.; Springer-Verlag: New York, 1997; Vol. 70, pp 81-288.
6. (f) Zafra-Polo, M. C.; Figadere, B.; Gallardo, T.; Tormo, J. R.; Cortes, D. Phytochemistry 1998, 48, 1087-1117.
7. (g) Alali, F. Q.; Liu, X. X.; McLaughlin, J. L. J. Nat. Prod. 1999, 62, 504-540.
8. For reviews of acetogenin synthesis up to 1998, see refs 1 and: (a) Hoppe, R.; Scharf, H. D. Synthesis 1995, 1447-1464.
9. (b) Figadère, B.; Cavé, A. In Studies in Natural Products Chemistry; Atta-ur-Rahman, Ed.; Elsevier Science B. V.: Amsterdam, 1996; Vol. 18, pp 193-227.
10. (c) Marshall, J. A.; Hinkle, K. W.; Hagedorn, C. E. Isr. J. Chem. 1997, 37, 97-107.
11. (d) Casiraghi, G.; Zanardi, F.; Battistini, L.; Rassu, G.; Appendino, G. ChemTracts-Org. Chem. 1998, 11, 803-827.
12. Jolad, S. D.; Hoffmann, J. J.; Schram, K. H.; Cole, J. R.; Tempesta, M. S.; Kriek, G. R.; Bates, R. B. J. Org. Chem. 1982, 47, 3151-3153.
13. For a selection of approaches to the total synthesis of Annonaceous acetogenins: (a) Hoye, T. R.; Hanson, P. R.; Kovelesky, A. C.; Ocain, T. D.; Zhuang, Z. P. J. Am. Chem. Soc. 1991, 113, 9369-9371.
14. (b) Hoye, T. R.; Ye, Z. X. J. Am. Chem. Soc. 1996, 118, 1801-1802.
15. (c) Hoye, T. R.; Hanson, P. R. Tetrahedron Lett. 1993, 34, 5043-5046.
16. (d) Figadere, B.; Chaboche, C.; Peyrat, J. F.; Cave, A. Tetrahedron Lett. 1993, 34, 8093-8096.
17. (e) Figadère, B. Acc. Chem. Res. 1995, 28, 359-365.
18. (f) Rao, A. V. R.; Reddy, K. L. N.; Reddy, K. A. Ind. J. Chem. Sect. B-Org. Chem. Inc. Med. Chem. 1993, 32, 1203-1208.
19. (g) Baurle, S.; Hoppen, S.; Koert, U. Angew. Chem., Int. Ed. 1999, 38, 1263-1266.
20. (h) Emde, U.; Koert, U. Eur. J. Org. Chem. 2000, 1889-1904.
21. (i) Marshall, J. A.; Jiang, H. J. J. Org. Chem. 1998, 63, 7066-7071.
22. (j) Marshall, J. A.; Piettre, A.; Paige, M. A.; Valeriote, F. J. Org. Chem. 2003, 68, 1771-1779.
23. (k) Sinha, S. C.; Sinha, A.; Sinha, S. C.; Keinan, E. J. Am. Chem. Soc. 1998, 120, 4017-4018.
24. (l) Avedissian, H.; Sinha, S. C.; Yazbak, A.; Sinha, A.; Neogi, P.; Sinha, S. C.; Keinan, E. J. Org. Chem. 2000, 65, 6035-6051.
25. (m) Trost, B. M.; Calkins, T. L.; Bochet, C. G. Angew. Chem., Int. Ed. 1997, 36, 2632-2635.
26. (n) Hanessian, S.; Grillo, T. A. J. Org. Chem. 1998, 63, 1049-1057.
27. (o) Kuriyama, W.; Ishigami, K.; Kitahara, T. Heterocycles 1999, 50, 981-988.
28. (p) Yu, Q.; Wu, Y. K.; Ding, H.; Wu, Y. L. J. Chem. Soc., Perkin Trans. 1 1999, 1183-1188.
29. (q) Ruan, Z. M.; Dabideen, D.; Blumenstein, M.; Mootoo, D. R. Tetrahedron 2000, 56, 9203-9211.
30. (r) Zanardi, F.; Battistini, L.; Rassu, G.; Auzzas, L.; Pinna, L.; Marzocchi, L.; Acquotti, D.; Casiraghi, G. J. Org. Chem. 2000, 65, 2048-2064.
31. (s) Hu, T. S.; Yu, Q.; Wu, Y. L.; Wu, Y. K. J. Org. Chem. 2001, 66, 853-861.
32. (t) Zhang, H. P.; Dabideen, D.; Pushchinska, G.; Mootoo, D. R. J. Carbohydr. Chem. 2002, 21, 411-430.
33. (u) Dixon, D. J.; Ley, S. V.; Reynolds, D. J. Chem. Eur. J. 2002, 8, 1621-1636.
34. For examples of the stereoselective synthesis of cis-mono-THF Annonaceous acetogenins, see the following. 15,20-Di-epi-cis-solamin: (a) Makabe, H.; Tanaka, A.; Oritani, T. J. Chem. Soc., -Perkin Trans. 1 1994, 1975-1981.
35. Muricatetrocin A: (b) Bäurle, S.; Peters, U.; Friedrich, T.; Koert, U. Eur. J. Org. Chem. 2000, 65, 2207-2217.
36. cis-Solamin: (c) Makabe, H.; Hattori, Y.; Tanaka, A.; Oritani, T. Org. Lett. 2002, 4, 1083-1085.
37. (d) For a preliminary communication of part of this work: Cecil, A. R. L.; Brown, R. C. D. Org. Lett. 2002, 4, 3715-3718.
38. For syntheses of other acetogenins where one of the THF rings is cis-2,5-disubstituted, see the following. Jimenezin (revised structure): (a) Takahashi, S.; Maeda, K.; Hirota, S.; Nakata, T. Org. Lett. 1999, 1, 2025-2028.
39. Trilobin: (b) Marshall, J. A.; Jiang, H. J. J. Org. Chem. 1999, 64, 971-975.
40. Rollidecins C and D: (c) D'Souza, L. J.; Sinha, S. C.; Lu, S. F.; Keinan, E.; Sinha, S. C. Tetrahedron 2001, 57, 5255-5262.
41. Gleye, C.; Duret, P.; Laurens, A.; Hocquemiller, R.; Cavé, A. J. Nat. Prod. 1998, 61, 576-579.
42. Duncan, R. Nat. Rev. Drug Discov. 2003, 2, 347-360.
43. Trost, B. M.; Müller, T. J. J.; Martinez, J. J. Am. Chem. Soc. 1995, 117, 1888-1899.
44. 4: (a) Klein, E.; Rojahn, W. Tetrahedron 1979, 21, 2353-2358.
45. (b) Baldwin, J. E.; Crossley, M. J.; Lehtonen, E.-M. M. J. Chem. Soc., Chem. Commun. 1979, 918-919.
46. (c) Walba, D. M.; Wand, M. D.; Wilkes, M. C. J. Am. Chem. Soc. 1979, 101, 4396-4397.
47. (d) Walba, D. M.; Edwards, P. D. Tetrahedron Lett. 1980, 21, 3531-3534.
48. (e) Spino, C.; Weiler, L. Tetrahedron Lett. 1987, 28, 731-734.
49. (f) Walba, D. M.; Przybyla, C. A.; Walker, C. B. J. J. Am. Chem. Soc. 1990, 112, 5624-5625.
50. (g) Kocienski, P. J.; Brown, R. C. D.; Pommier, A.; Procter, M.; Schmidt, B. J. Chem. Soc., Perkin Trans. 1 1998, 9-39.
51. (h) Brown, R. C. D.; Hughes, R. M.; Keily, J.; Kenney, A. Chem. Commun. 2000, 1735-1736.
52. (i) Brown, R. C. D.; Bataille, C. J.; Hughes, R. M.; Kenney, A.; Luker, T. J. J. Org. Chem. 2002, 67, 8079-8085.
53. For examples of the oxidative cyclization of 1,5-dienes using other metal-oxo species, see the following. Ruthenium: (a) Carlsen, P. H. J.; Katsuki, T.; Martin, V. S.; Sharpless, K. B. J. Org. Chem. 1981, 46, 3936-3938.
54. (b) Piccialli, V.; Cavallo, N. Tetrahedron Lett. 2001, 42, 4695-4699.
55. (c) Albarella, L.; Musumeci, D.; Sica, D. Eur. J. Org. Chem. 2001, 997-1003.
56. (d) Bifulco, G.; Caserta, T.; Gomez-Paloma, L.; Piccialli, V. Tetrahedron Lett. 2003, 44, 3429-3429.
57. Osmium: (e) Donohoe, T. J.; Winter, J. J. G.; Helliwell, M.; Stemp, G. Tetrahedron Lett. 2001, 42, 971-974.
58. (f) de Champdore, M.; Lasalvia, M.; Piccialli, V. Tetrahedron Lett. 1998, 39, 9781-9784.
59. (g) Donohoe, T. J.; Butterworth: S. Angew. Chem., Int. Ed. 2003, 42, 978-981.
60. For related oxidative cyclizations of hydroxy olefins by metal-oxo species, see refs 41, 6c, and: (a) Walba, D. M.; Stoudt, G. S. Tetrahedron Lett. 1982, 23, 727-730.
61. (b) Tang, S. H.; Kennedy, R. M. Tetrahedron Lett. 1992, 33, 5299-5302.
62. (c) Tang, S. H.; Kennedy, R. M. Tetrahedron Lett. 1992, 33, 5303-5306.
63. (d) McDonald, F. E.; Towne, T. B. J. Am. Chem. Soc. 1994, 116, 7921-7922.
64. (e) McDonald, F. E.; Towne, T. B. J. Org. Chem. 1995, 60, 5750-5751.
65. (f) Towne, T. B.; McDonald, F. E. J. Am. Chem. Soc. 1997, 119, 6022-6028.
66. (g) Morimoto, Y.; Iwai, T.; Kinoshita, T. J. Am. Chem. Soc. 1999, 121, 6792-6797.
67. (h) Keinan, E.; Sinha, S. C. Pure Appl. Chem. 2002, 74, 93-105.
68. Jan, S.-T.; Li, K.; Vig, S.; Rudolph, A.; Uckun, F. M. Tetrahedron Lett. 1999, 40, 193-196.
69. Makabe, H.; Tanimoto, H.; Tanaka, A.; Oritani, T. Heterocycles, 1996, 43, 2229-2248.
70. Takacs, J. M.; Helle, M. A.; Seely, F. L. Tetrahedron Lett. 1986, 27, 1257-1260.
71. Oppolzer, W.; Dupuis, D.; Poli, G.; Raynham, T. M.; Bernardinelli, G. Tetrahedron Lett. 1988, 29, 5885-5888.
72. (a) Gale, J. B.; Yu, J.-G.; Hu, X. E.; Khare, A.; Ho, D. K.; Cassady, J. M. Tetrahedron Lett. 1993, 34, 5847-5850.
73. (b) Bertrand, P.; Gesson, J. P. Tetrahedron Lett. 1992, 33, 5177-5180.
74. The stereochemistry of the major diastereoisomer was assigned on the basis of literature precedent for the oxidative cyclization of closely related substrates (see ref 10f,i).
75. Cecil, A. R. L.; Brown, R. C. D. Arkivoc 2001, Part (xi) Commemorative Issue in Honor of Prof. B. S. Thyagarajan, ms. BT-336D (http://www.Arkat-usa.org/ark/journal/Volume2/Part3/Thyagarajan/BT-335D/336d. pdf).
76. Brown, R. C. D.; Keily, J. F. Angew. Chem., Int. Ed. 2001, 40, 4496-4498.
77. major signals, leading us to initially report a higher value of 10:1. The dr value of 6:1 was confirmed from the isolated yields of 5 and 16.
78. The diastereofacial selectivity observed for the oxidative cyclization of enantiomerically enriched N-enoyl oxazolidinones was previously explained by dipolar organization of the substrate (see ref 10f).
79. Reiser, O. In Organic Synthesis Highlights IV; Schmalz, H.-G., Ed.; Wiley-VCH: Weinheim, 2000; pp 11-16.
80. 13C NMR spectra.
81. Marshall, J. A.; Chen, M. J. Org. Chem. 1997, 62, 5996-6000.
82. 3).
83. It has previously been observed that the optical rotation value of acetogenins is largely due to the stereochemistry of the butenolide, and to a lesser extent due to the stereochemistry of the THF diol portion: Duret, P.; Figadère, B.; Hocquemiller, R.; Cavé, A. Tetrahedron Lett. 1997, 38, 8849-8852.
84. Each of the four isomers (1, ent-1, 2, and ent-2) gave a separate and single peak on a Chiral CD-Ph HPLC column, eluting with i-PrOH/hexane (15:85). Retention times: 1 (14.5 min), 2 (17.3 min), ent-1 (18.7 min), ent-2 (15.7 min). See the Supporting Information for an HPLC trace for a mixed sample of 1 and 2.
85. Sgouras, D.; Duncan, R. J. Mater. Sci.: Mater. Med. 1990, 1, 61-68.